secwatch.observer — SEC 8-K summary
======================================

Issuer:     Immunovant, Inc. (IMVT)
CIK:        0001764013
Form:       8-K
Filed at:   2025-01-24T23:59:59+00:00
Accession:  0001193125-25-012329
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Immunovant files prospectus supplement to register 5.65M shares for resale by selling stockholders
--------------------------------------------------------------------------------

- Filed prospectus supplement to register up to 5,654,990 shares of common stock for resale by selling stockholders.
- Shares were acquired by selling stockholders in private placement financing reported on January 13, 2025.
- Opinion of counsel Cooley LLP regarding legality of shares filed as Exhibit 5.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1764013/000119312525012329/0001193125-25-012329-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1764013/000119312525012329/d920756d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-012329

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer